Inventor · disambiguated record
Alisha K. Weight
Also filed as: WEIGHT ALISHA · WEIGHT ALISHA K
11 granted patents·8 pending applications·21 citations·filing 2013–2024
89Inventor score
Top patents by PatentIndex Score
19 records- 0190US2024181063A1Liquid Protein Formulations Containing Viscosity-Lowering AgentsEAGLE BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 0290US2024285766A1Liquid Protein Formulations Containing Ionic LiquidsEAGLE BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 0389US10849977B2Liquid Protein Formulations Containing ThiamineEAGLE BIOLOGICS INC·Filed 2018·Granted Dec 1, 2020·2 cites·20 claims
- 0489US10821184B2Liquid protein formulations containing thiamine pyrophosphate (TPP)EAGLE BIOLOGICS INC·Filed 2018·Granted Nov 3, 2020·2 cites·22 claims
- 0587US11471479B2Polysaccharide and nucleic acid formulations containing viscosity-lowering agentsEAGLE BIOLOGICS INC·Filed 2015·Granted Oct 18, 2022·3 cites·32 claims
- 0687US10646571B2Liquid protein formulations containing cimetidineEAGLE BIOLOGICS INC·Filed 2018·Granted May 12, 2020·1 cites·20 claims
- 0787US9913905B2Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereofEAGLE BIOLOGICS INC·Filed 2014·Granted Mar 13, 2018·5 cites·25 claims
- 0886US9833513B2Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereofEAGLE BIOLOGICS INC·Filed 2014·Granted Dec 5, 2017·4 cites·26 claims
- 0984US9925263B2Liquid pharmaceutical formulations for injection comprising procaine and uses thereofEAGLE BIOLOGICS INC·Filed 2014·Granted Mar 27, 2018·3 cites·24 claims
- 1077US11986526B2Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)EAGLE BIOLOGICS INC·Filed 2020·Granted May 21, 2024·0 cites·24 claims
- 1177US11819550B2Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)EAGLE BIOLOGICS INC·Filed 2020·Granted Nov 21, 2023·0 cites·28 claims
- 1277US10179172B2Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereofEAGLE BIOLOGICS INC·Filed 2014·Granted Jan 15, 2019·1 cites·27 claims
- 1377US2021085792A1Liquid Protein Formulations Containing Viscosity-Lowering AgentsEAGLE BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 1470US10821183B2Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)EAGLE BIOLOGICS INC·Filed 2017·Granted Nov 3, 2020·0 cites·23 claims
- 1553US2024390270A1Gastric residence systems for administration of risperidoneLYNDRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1647US2022387311A1Gastric residence systems for administration of active agentsLYNDRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1747US2022387310A1Formulations for release-rate modulating films for gastric residence systemsLYNDRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1846US2021196627A1Systems for enteric delivery of therapeutic agentsLYNDRA INC·Filed 2019·Application pending·0 cites
- 1945US2013280204A1Polymer-Attached Inhibitors of Influenza VirusMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →